9,459 Ingevity Corporation $NGVT Shares Sold by Leeward Investments LLC MA

Leeward Investments LLC MA reduced its position in shares of Ingevity Corporation (NYSE:NGVT) by 5.8% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 153,075 shares of the company’s stock after selling 9,459 shares during the period. Leeward Investments LLC MA’s holdings in Ingevity were worth $10,830,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Frazier Financial Advisors LLC bought a new stake in Ingevity in the second quarter valued at $37,000. Global Retirement Partners LLC bought a new stake in Ingevity during the 2nd quarter valued at $45,000. Harbor Investment Advisory LLC acquired a new position in Ingevity during the 2nd quarter worth $71,000. Public Employees Retirement System of Ohio acquired a new position in Ingevity during the 2nd quarter worth $75,000. Finally, Assetmark Inc. grew its stake in shares of Ingevity by 9.6% in the first quarter. Assetmark Inc. now owns 1,584 shares of the company’s stock worth $113,000 after purchasing an additional 139 shares in the last quarter. Institutional investors and hedge funds own 91.59% of the company’s stock.

Insider Activity

In related news, CEO David Li sold 5,000 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $75.83, for a total transaction of $379,150.00. Following the completion of the transaction, the chief executive officer owned 120,636 shares of the company’s stock, valued at $9,147,827.88. This trade represents a 3.98% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Ryan Fisher sold 2,709 shares of Ingevity stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the transaction, the senior vice president directly owned 15,722 shares in the company, valued at approximately $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 17,801 shares of company stock valued at $1,347,481 in the last ninety days. Company insiders own 0.88% of the company’s stock.

Ingevity Price Performance

NYSE NGVT opened at $69.73 on Monday. Ingevity Corporation has a 12 month low of $45.85 and a 12 month high of $79.29. The company has a debt-to-equity ratio of 22.52, a current ratio of 1.61 and a quick ratio of 1.15. The firm has a market capitalization of $2.40 billion, a PE ratio of 47.44 and a beta of 1.14. The company’s 50 day simple moving average is $70.28 and its 200 day simple moving average is $71.85.

Ingevity (NYSE:NGVT) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%. The company had revenue of $314.10 million for the quarter, compared to analysts’ expectations of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. As a group, equities research analysts forecast that Ingevity Corporation will post 5.40 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on NGVT shares. Wall Street Zen lowered Ingevity from a “strong-buy” rating to a “buy” rating in a report on Saturday, August 1st. Weiss Ratings downgraded shares of Ingevity from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday. Two analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat.com, Ingevity presently has an average rating of “Hold” and a consensus price target of $80.00.

Ingevity Company Profile

Ingevity Corporation (NYSE: NGVT) is a specialty chemicals and materials company that develops products designed to improve performance, efficiency, and sustainability across a range of industrial and consumer applications. Its offerings serve markets including automotive, transportation, agriculture, coatings, adhesives, pavement markings, and industrial manufacturing.

The company is best known for activated carbon products used in automotive vapor-emission control systems, where they help capture fuel vapors and reduce emissions.